miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 22, 2026

Crypto News: Pepeto Updates Binance Level Exchange And Ethereum Price Prediction Aims $7,500 Despite Crypto Crash

View original at globenewswire.com
Crypto News: Pepeto Updates Binance Level Exchange And Ethereum Price Prediction Aims $7,500 Despite Crypto Crash Dubai, UAE, March 22, 2026 (GLOBE NEWSWIRE) -- The Pepeto team just hit a big milestone on its Binance level exchange, finishing the order book engine and the multi chain liquidity system as the project mov…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Pepeto reaching $100 million market cap from presale pricing gives over 50x returns

    60% confidence
  • Ethereum price at $7,500 gives ETH holders 3.5x returns from current levels

    60% confidence
  • Wider analyst range for Ethereum goes from $4,500 to $10,000 as Glamsterdam upgrade and ETF inflows lift price

    60% confidence
  • The platform runs zero cost swaps on Ethereum, cuts out the gas fees that make small trades pointless on other DeFi platforms, moves coins between Ethereum, BNB Chain, and Solana instantly with no bridging cost, and runs AI checks on every listed token looking for honeypot tricks, hidden mint tools, and rug pull code before it can be traded

    60% confidence
  • Extreme fear lasting 46 straight days has only happened four times since 2018, and every time marked the start of that cycle's biggest recovery

    60% confidence
  • Ethereum price will reach $7,500 by end of 2026

    60% confidence
  • Multiple research teams predict Ethereum price between $4,500 and $7,500 for end of 2026

    60% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Crypto News: Pepeto Updates Binance Level Exchange And Ethereum Price Prediction Aims $7,500 Despite Crypto Crash — Source | Via News | es.VIA.NEWS